FOR US AUDIENCES ONLY
Join us at PCRS 2024 for Hands-on HyFoSy Training Booth #114 & 115 We are thrilled to align with the PCRS 2024 conference theme of "Innovation and Integration" by fostering a learning environment of collaboration and knowledge exchange. Visit the ExEm® Foam Booth for a Hands-on HyFoSy / ExEm® Foam experience utilizing the latest GE Voluson™ ultrasound [...]
RSVP for a One-on-One Hands-On Training and Product Samples (Limited seats/inventory, First come-first served) The 2023 ASRM Scientific Congress & Expo in New Orleans, Louisiana offers new CME and hands-on training sessions led by industry experts featuring the latest advancements in streamlined fertility diagnostics using ExEm® Foam and the [...]
IQ Medical and Richter announce the sale and purchase of Giskit MD B.V. Rotterdam, the Netherlands and Budapest, Hungary – 20 July 2023 – Gedeon Richter Plc. (“Richter”) and IQ Medical Ventures B.V. (“IQ Medical”) announced today that they signed a Share Purchase Agreement to transfer 100% of [...]
Revolutionizing Tubal Patency Assessments: ExEm® Foam/HyFoSy Exhibition Debut at the 21st Annual Meeting of MRSi in Chicago, Illinois from June 8th to the 10th. Visit us at Booth #25. RSVP for a One-on-One Meeting and Product Samples (Limited inventory, First come-first served) ExEm® Foam and the HyFoSy Procedure [...]
Experience ExEm® Foam & the HyFoSy Procedure at the ARM & NPG Joint Meeting in Denver, Colorado, May 5 - 7 RSVP for a One-on-One Meeting and Product Samples (Limited inventory, First come-first served) Experience first-hand the effective ultrasound tubal patency assessment using ExEm® Foam and the HyFoSy Procedure [...]
ExEm® Foam HyFoSy Exhibition at the PCRS 2023 Annual Meeting in Indian Wells, California In alignment with this year’s meeting theme of “Putting Patients First”, we are pleased to present the patient-friendly benefits of the HyFoSy Procedure and ExEm® Foam, a clinically-proven and gentle ultrasound tubal patency assessment [...]
Learn about the only option comparable to the Gold Standard for tubal patency testing.1 Attend one of our in-booth presentations with live demonstrations during the American Society for Reproductive Medicine (ASRM) 2022 Congress and Expo. This year’s congress will take place at the Anaheim Convention Center in California from [...]
Learn about the Hysterosalpingo Foam Sonography (HyFoSy) Procedure at the ACOG 2022 Annual Clinic and Scientific Meeting being held in San Diego, California. This year the meeting takes place at the San Diego Convention Center from May 6 – May 8, 2022. We welcome you to visit our booth [...]
Learn about the Hysterosalpingo Foam Sonography (HyFoSy) Procedure at the 70th Annual Pacific Coast Reproductive Society (PCRS) Meeting, a forum focused on professional development in the field of reproductive medicine. This year the meeting returns to in-person participation at the Esmeralda Renaissance Resort from March 24 - 26, 2022. [...]
ExEm® Foam Inc. is pleased to be an Exhibitor at the AIUM 45th Annual Advanced OB-GYN Ultrasound Seminar taking place at the Disney Yacht and Beach Club Resorts in Lake Buena Vista, Florida from February 17 – 19, 2022. Visit the ExEm® Foam booth to view a live educational demonstration [...]
ExEm® Foam is an innovative, FDA-approved product that offers a less invasive and effective alternative to other tubal patency assessment procedures, like laparoscopy or X-Ray HSG.
ExEm® Foam Inc. is an affiliate of IQ MEDICAL VENTURES, B.V. ExEm® is a registered trademark of GISKIT PHARMA B.V.
Important Safety Information: ExEm® Foam should not be used on patients who are pregnant, have known or suspected lower genital tract inflammation or infection, have had a gynecologic procedure within the last 30 days, have vaginal bleeding, or have known or suspected reproductive tract neoplasia. Common side effects include pelvic and abdominal pain, vasovagal reactions (and associated symptoms such as nausea and faintness), and post-procedure spotting. Click here for full prescribing information.
References:
1. Ludwin I., Ludwin, A. et al. Accuracy of hysterosalpingo-foam sonography in comparison to hysterosalpingo-contrast sonography with air/saline and to laparoscopy with dye. Human Reproduction 2017, 32(4):758–69
2. Riganelli L., Casorelli A. et al. Ultrasonography reappraisal of tubal patency in assisted reproduction technology patients: comparison between 2D and3D-sonohysterosalpingography. A pilot study. Minerva Ginecologica 2018, 70(2):123-28
3. Dreyer, K., Out, R. et al. Hysterosalpingo-foam sonography, a less painful procedure for tubal patency testing during fertility workup compared with (serial) hysterosalpingography: A randomized controlled trial. Fertility and Sterility 2014, 102(3):821-25
ExEm_US_02_v27
ExEm® Foam Inc. is an affiliate of IQ MEDICAL VENTURES, B.V. ExEm® is a registered trademark of GISKIT PHARMA B.V.
